Safety and Efficacy of Ginsenoside Rg3 in Combination With First-line Chemotherapy in Advanced Gastric Cancer

• Status: Unknown status
• Trial end date: 2016-12-01
• Target enrollment: 0
• Participant gender: All

Summary

Safety and Efficacy of Ginsenoside Rg3 in Combination with First-line Chemotherapy in Advanced Gastric Cancer.The purpose of this study is to assess the safety of Ginsenoside Rg3 in advanced gastric cancer, and whether it improves the efficacy of first-line chemotherapy.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hebei Tumor Hospital
• Treatments: Ginsenoside Rg3

Criteria

Inclusion Criteria:

1. Signed informed consent form

2. Performance Status- Eastern Cooperative Oncology Group (ECOG) 0-1;

3. Histologically or cytologically confirmed gastric cancer;

4. At least have one measurable disease(according to RECIST, Response Evaluation Criteria in Solid Tumors )

5. Life expectancy of at least 3 months;

Exclusion Criteria:

1. Received any prior treatment including Ginsenoside Rg3;

2. Active or uncontrolled infection;

3. Concurrent treatment with an investigational agent or participation in another therapeutic clinical trial;

4. Pregnant or lactating women.